Prior to joining Ortho, Smith served as the CEO of Cochlear Limited, a publicly-traded global medical device company headquartered in Australia, from 2015 through 2018. Under his leadership, Cochlear Limited reached annual sales in excess of AU$1 billion while the market cap of the company more than doubled. While CEO, Smith led a strategy focused on customer experience, globalization, service expansion and product innovation. Smith also served as the president of Cochlear Americas for more than a decade, more than quadrupling revenue during his tenure.
Prior to Cochlear, Smith held several senior executive roles, including CEO in residence for Warburg Pincus and global group president of Gyrus Group Plc., a surgical products company. As CEO of Gyrus Medical, he grew revenue and expanded operating profit. He also held leadership roles with KCI, a health care company focused on wound care, Prism, an information technology company, and the health care services company Cardinal Health. He earlier worked for Abbott’s pharmaceutical products and physician office diagnostics divisions.
Smith serves on the boards of directors of several companies, including Results Physiotherapy, Nyxoah and Akouos, and was a senior external advisor for McKinsey & Co., AngelMD and EQT Partners. He previously served on the boards of directors of publicly-listed Xtent Inc. as well as Startek Inc., Universal Biosensors, Gyrus Group Plc, and Acclarent Inc.
Smith holds a Bachelor of Science degree from Texas A&M University.
What is Christopher M. Smith's net worth?
The estimated net worth of Christopher M. Smith is at least $9.42 million as of August 2nd, 2021. Mr. Smith owns 534,147 shares of Ortho Clinical Diagnostics stock worth more than $9,417,012 as of April 23rd. This net worth approximation does not reflect any other investments that Mr. Smith may own. Additionally, Mr. Smith receives a salary of $2,850,000.00 as CEO at Ortho Clinical Diagnostics. Learn More about Christopher M. Smith's net worth.
How old is Christopher M. Smith?
What is Christopher M. Smith's salary?
How do I contact Christopher M. Smith?
Has Christopher M. Smith been buying or selling shares of Ortho Clinical Diagnostics?
Christopher M. Smith has not been actively trading shares of Ortho Clinical Diagnostics during the past quarter. Most recently, Christopher M. Smith sold 61,800 shares of the business's stock in a transaction on Wednesday, August 4th. The shares were sold at an average price of $21.79, for a transaction totalling $1,346,622.00. Following the completion of the sale, the chief executive officer now directly owns 534,147 shares of the company's stock, valued at $11,639,063.13. Learn More on Christopher M. Smith's trading history.
Who are Ortho Clinical Diagnostics' active insiders?
